Trade NVAX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Novavax, Inc. (NVAX) is trading at US$11.26, down 12.17% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$1.47B. Over the past 52 weeks, NVAX has traded between US$6.20 and US$13.39. On Syfe you can trade NVAX with $0 commission and add it to your watchlist.
| Previous close | US$12.82 |
|---|---|
| Market cap | US$1.47B |
| 52-week range | US$6.20 – US$13.39 |
| Volume | 9.86M |
| Exchange | US |
Novavax, Inc.
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Year: 1995
Novavax, Inc. (NVAX) stock is trading at US$11.26, -12.17% from the previous close of US$12.82.
The market cap for Novavax, Inc. (NVAX) stock is approximately US$1.47B.
The 52-week high for Novavax, Inc. (NVAX) stock is US$13.39.
The 52-week low for Novavax, Inc. (NVAX) stock is US$6.20.
Novavax, Inc. (NVAX) does not currently pay a dividend.
Stay on top of NVAX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
